These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32400048)

  • 21. Inhibition of Soluble Epoxide Hydrolase in Macrophages Ameliorates the Formation of Foam Cells　- Role of Heme Oxygenase-1.
    Peng H; Tang J; Zhao S; Shen L; Xu D
    Circ J; 2019 Nov; 83(12):2555-2566. PubMed ID: 31666457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.
    Tu R; Armstrong J; Lee KSS; Hammock BD; Sapirstein A; Koehler RC
    Sci Rep; 2018 Mar; 8(1):5279. PubMed ID: 29588470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
    Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling.
    Zhou C; Huang J; Li Q; Nie J; Xu X; Wang DW
    Sci Rep; 2017 Jul; 7(1):6926. PubMed ID: 28761179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease.
    Ghosh A; Comerota MM; Wan D; Chen F; Propson NE; Hwang SH; Hammock BD; Zheng H
    Sci Transl Med; 2020 Dec; 12(573):. PubMed ID: 33298560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions.
    Chen Z; Tang Y; Yu J; Dong R; Yang Y; Fu M; Luo J; Hu S; Wang DW; Tu L; Xu X
    Shock; 2020 Jun; 53(6):761-771. PubMed ID: 31318834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous Target-Mediated Drug Disposition Model for Two Small-Molecule Compounds Competing for Their Pharmacological Target: Soluble Epoxide Hydrolase.
    Wu N; Hammock BD; Lee KSS; An G
    J Pharmacol Exp Ther; 2020 Jul; 374(1):223-232. PubMed ID: 32238455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats.
    Bukhari IA; Mohamed OY; Mahmood A; Alfadda AA; Almotrefi AA
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(10):3835-3847. PubMed ID: 34109592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
    Bukhari IA; Alorainey BI; Al-Motrefi AA; Mahmoud A; Campbell WB; Hammock BD
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8143-8150. PubMed ID: 32767352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TPPU enhanced exercise-induced epoxyeicosatrienoic acid concentrations to exert cardioprotection in mice after myocardial infarction.
    Guo Y; Luo F; Zhang X; Chen J; Shen L; Zhu Y; Xu D
    J Cell Mol Med; 2018 Mar; 22(3):1489-1500. PubMed ID: 29265525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.
    Wan X; Fujita Y; Chang L; Wei Y; Ma L; Wuyun G; Pu Y; Hammock BD; Hashimoto K
    Neuropsychopharmacol Rep; 2020 Dec; 40(4):412-416. PubMed ID: 32896112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
    Ulu A; Appt S; Morisseau C; Hwang SH; Jones PD; Rose TE; Dong H; Lango J; Yang J; Tsai HJ; Miyabe C; Fortenbach C; Adams MR; Hammock BD
    Br J Pharmacol; 2012 Mar; 165(5):1401-12. PubMed ID: 21880036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation.
    Ma M; Ren Q; Yang J; Zhang K; Xiong Z; Ishima T; Pu Y; Hwang SH; Toyoshima M; Iwayama Y; Hisano Y; Yoshikawa T; Hammock BD; Hashimoto K
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7083-7088. PubMed ID: 30890645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPPU treatment of burned mice dampens inflammation and generation of bioactive DHET which impairs neutrophil function.
    Bergmann CB; Hammock BD; Wan D; Gogolla F; Goetzman H; Caldwell CC; Supp DM
    Sci Rep; 2021 Aug; 11(1):16555. PubMed ID: 34400718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.
    Shen Y; Peng W; Chen Q; Hammock BD; Liu J; Li D; Yang J; Ding J; Wang X
    Brain Behav Immun; 2019 Oct; 81():535-544. PubMed ID: 31306773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice.
    Chen Y; Tian H; Yao E; Tian Y; Zhang H; Xu L; Yu Z; Fang Y; Wang W; Du P; Xie M
    Sci Rep; 2017 Aug; 7(1):7758. PubMed ID: 28798352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.
    Goswami SK; Rand AA; Wan D; Yang J; Inceoglu B; Thomas M; Morisseau C; Yang GY; Hammock BD
    Life Sci; 2017 Jul; 180():114-122. PubMed ID: 28522175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble epoxide hydrolase inhibitor blockage microglial cell activation in subnucleus caudalis in a persistent model of arthritis.
    Tarkany Basting R; Henrique Napimoga M; Antônio Trindade Silva C; Ballassini Abdalla H; Campos Durso B; Henrique Barboza Martins L; de Abreu Cavalcanti H; Hammock BD; Trindade Clemente-Napimoga J
    Int Immunopharmacol; 2023 Jul; 120():110320. PubMed ID: 37230034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of soluble epoxide hydrolase attenuates a high-fat diet-mediated renal injury by activating PAX2 and AMPK.
    Luo Y; Wu MY; Deng BQ; Huang J; Hwang SH; Li MY; Zhou CY; Zhang QY; Yu HB; Zhao DK; Zhang G; Qin L; Peng A; Hammock BD; Liu JY
    Proc Natl Acad Sci U S A; 2019 Mar; 116(11):5154-5159. PubMed ID: 30804206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TPPU, a sEH Inhibitor, Attenuates Corticosterone-Induced PC12 Cell Injury by Modulation of BDNF-TrkB Pathway.
    Wu Q; Song J; Meng D; Chang Q
    J Mol Neurosci; 2019 Mar; 67(3):364-372. PubMed ID: 30644034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.